Ochsner Home Health Of Covington Location: 100 Innwood Drive Suite C, Covington, Louisiana 70433 Ratings: Phone: (985) 892-7627 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
St. Tammany Hospital Home Health Location: 725 West 11th Ave, Covington, Louisiana 70433 Ratings: Phone: (985) 898-4414 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Pulse Home Health Care Location: 19295 North 3rd Street, Suite 14, Covington, Louisiana 70433 Ratings: Phone: (985) 845-7088 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Interim Healthcare Of Southeast La Inc Location: 71677 Riverside Drive, Covington, Louisiana 70433 Ratings: Phone: (985) 674-1699 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
The Brain & Behavior Research Foundation celebrates the transformative power of neuroscience and psychiatric research to improve the lives of those with mental illness. Seven exceptional scientists will be honored at the Annual National Awards Dinner at the Pierre Hotel in New York City on Friday, October 25, 2013.
Hemispherx Biopharma, Inc., announced that the Company has requested an extension of time in which to resubmit data to its NDA for Ampligen®, an experimental therapeutic, to treat CFS.
As the COVID-19 pandemic has changed how plastic surgeons will care for patients and how they operate their practices, the American Society of Plastic Surgeons (ASPS) recently conducted a member survey to understand what procedures were top of mind among patients to gauge whether the public's mindset on preferred treatments has shifted.
The number of reported cases of child neglect in the United States of America increased as a result of the spike in unemployment following the financial crisis of 2007-08, according to new Oxford University research.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain today announced that it has initiated enrollment in its Phase 3 clinical study for Oxycodone DETERx (COL-003).
› Verified 3 days ago